Chemistry of Heterocyclic Compounds 2018, 54(12), 1127–1130
(2H, d, J = 7.6, H-2,6 PhCO). 13C NMR spectrum (DMSO-d6),
128.0 (C-2,6 Ph); 128.9 (C-3,5 Ph); 129.0 (2 signals, C-2,6
PhCO); 129.1 (C-3,5 PhCO); 130.1 (C-4 Ph); 131.1; 134.2;
135.3; 135.9; 141.9; 143.2; 145.3 (C-5 Fur); 150.9; 157.0;
195.2 (С=О).
δ, ppm: 17.5 (2-CH3); 36.5 (C-4); 105.2 (C-3 Fur); 110.7
(C-4 Fur); 113.3; 119.7; 128.2 (C-2,3,5,6 Ph); 128.5 (C-2,6
PhCO); 128.9 (C-3,5 PhCO); 129.8; 132.5 (C-4 Ph); 133.8;
139.1; 139.8; 142.3 (C-5 Fur); 148.5; 155.4; 196.2 (С=О).
Preparation of compounds 10а–с (General method).
A mixture of 1,4-dihydropyridine 9a–c (1.0 mmol),
potassium nitrate (101 mg, 1.0 mmol), and copper(II)
nitrate trihydrate (24 mg, 0.1 mmol) in glacial acetic acid
(10 ml) and water (0.5 ml) was stirred at 50–60°С for
30 min (control by TLC). When the reaction was complete,
the solution was cooled, poured into ice–water mixture
(100 ml), and salted out using NaCl. The obtained
precipitate was filtered off, washed with water, and dried.
The filtrate was additionally extracted with ethyl acetate
(2×10 ml). The extract was dried over Na2SO4, and the
solvent was removed by distillation. The crystals isolated
from the extract were combined with the precipitate and
recrystallized from ethanol.
This work received financial support from the
Committee for Science, Ministry of Education and Science,
Republic of Kazakhstan (grant No. AP05131602).
References
1. Multicomponent Reactions: Synthesis of Bioactive
Heterocycles; Ameta, K. L.; Dandia, A., Eds.; CRC Press:
Boca Raton, 2017, 1st ed.
2. Dömling, A.; Wang, W.; Wang, K. Chem. Rev. 2012, 112, 3083.
3. Cioc, R. C.; Ruijter, E.; Orru, R. V. Green Chem. 2014, 16, 2958.
4. (a) Sharma, G. V.; Reddy, K. L.; Lakshmi, P. S.; Krishna, P. R.
Synthesis 2006, 55. (b) Debache, A.; Boulcina, R.; Belfaitah, A.;
Rhouati, S.; Carboni, B. Synlett 2008, 509. (c) Kumar, A.;
Maurya, R. A. Synlett 2008, 883.
5. Multicomponent Reactions; Herrera, R. P.; Marquéz-López, E.,
Eds.; John Wiley & Sons, Inc: Hoboken, 2015, p. 477.
6. Zhou, Y.; Kijima, T.; Kuwahara, S.; Watanabe, M.; Izumi, T.
Tetrahedron Lett. 2008, 49, 3757.
7. Brown, A. M.; Kunze, D. L.; Yatani A. Nature 1984, 311, 570.
8. Takahashi, D.; Oyunzul, L.; Onoue, S.; Ito, Y.; Uchida, S.;
Simsek, R.; Gunduz, M. G.; Safak, C.; Yamada, S. Biol.
Pharm. Bull. 2008, 31, 473.
9. (a) Garaliene, V.; Barsys, V.; Mačys A.; Vigante, B.; Krauze, A.
Eur. J Med Chem. 2011, 46, 4441. (b) Shan, R.; Velazquez, C.;
Knaus, E. E. J. Med. Chem. 2004, 47, 254. (c) Visentin, S.;
Rolando, B.; Di Stilo, A.; Frutterro, R.; Novara, M.; Carbone, E.;
Roussel, C.; Vanthuyne, N.; Gasco, A. J. Med. Chem. 2004,
47, 2688.
10. Vigante, B. A.; Terekhova, M. I.; Ozols, Ya. Ya.; Petrov, E. S.;
Dubur, G. Ya. Chem. Heterocycl. Compd. 1989, 25, 1028.
[Khim. Geterotsikl. Soedin. 1989, 1228.]
11. Sagitullina, G. P.; Glizdinskaya, L. V.; Sagitullin, R. S. Russ.
J. Org. Chem. 2007, 43, 602. [Zh. Org. Khim. 2007, 604.]
12. Zobenko, Y. A.; Pozhidaeva, S. A.; Kuratova, A. K.;
Glyzdinskaya, L. V.; Vorontsova, M. A.; Sagitullina, G. P.
Chem. Heterocycl. Compd. 2017, 53, 1014. [Khim. Geterotsikl.
Soedin. 2017, 1014.]
13. Bakhareva, S. V.; Berkova, G. A.; Vereshchagina, Ya. A.;
Fel'gendler, A. V.; Fattakhova, G. R. Russ. J. Gen. Chem.
2001, 71, 1942. [Zh. Obshch. Khim. 2001, 2049.]
14. Baraldi, P. G.; Simoni, D.; Manfredini, S. Synthesis 1983, 902.
15. Gavrilin, G. F.; Bykova, L. U.; Rogachkova, T. D.;
Novikova, É. I.; Savel'eva, G. S. Pharm. Chem. J. 1973, 7,
173 [Khim.-Farm. Zh. 1973, 7(3), 43.]
17. (a) Maquestiau, A.; Mayence, A.; Vanden Eynde, J. J.
Tetrahedron Lett. 1991, 32, 3839. (b) Ghorbani-
Choghamarani, A.; Zeinivand, J. Synth Commun. 2010, 40,
2457. (c) Balogh, M.; Hermecz, I.; Ménszáros, Z.; Laszlo, P.
Helv. Chim. Acta 1984, 67, 2270. (d) Sabitha, G.; Kumar
Reddy, G. S. K.; Reddy, C. S.; Fatima, N.; Yadav, J. S.
Synthesis 2003, 1267. (e) Mashraqui, S. H.; Karnik, M. A.
Synthesis 1998, 713. (f). Pfister, J. R. Synthesis 1990, 689.
1-[4-(Furan-2-yl)-2-methyl-5-nitro-6-phenylpyridin-3-yl]-
ethan-1-one (10a). Yield 268 mg (84%), beige crystals,
mp 126–128°С (ethanol) (mp 124–126°С11). IR spectrum,
1
ν, cm–1: 1249, 1353, 1566, 1709, 3131. H NMR spectrum
(CDCl3), δ, ppm (J, Hz): 2.24 (3H, s, CH3); 2.62 (3H, s,
CH3); 6.55 (1H, br. s, H-4 Fur); 6.77 (1H, d, J = 4.4, H-3
Fur); 7.45–7.50 (3H, m, H-5 Fur, H-3,5 Ph); 7.58–7.63
(3H, m, H-2,4,6 Ph). 13C NMR spectrum (CDCl3), δ, ppm:
23.0 (2-CH3); 30.9 (COCH3); 112.8 (C-3 Fur); 114.6 (C-4
Fur); 127.7; 128.0 (C-2,6 Ph); 128.9 (C-3,5 Ph); 130.1 (C-4
Ph); 133.2; 135.2; 142.0; 143.2; 145.7 (C-5 Fur); 150.5;
155.7; 202.3 (С=О).
Ethyl 4-(furan-2-yl)-2-methyl-5-nitro-6-phenylnicoti-
nate (10b). Yield 290 mg (83%), beige crystals, mp 117–
118°С (ethanol) (mp 116–117°С11). IR spectrum, ν, cm–1:
1273, 1360, 1536, 1598, 1726, 2982, 3143. 1H NMR
spectrum (CDCl3), δ, ppm (J, Hz): 1.27 (3H, t, J = 6.8,
OCH2CH3); 2.71 (3H, s, CH3); 4.34 (2H, q, J = 6.4,
OCH2CH3); 6.53 (1H, br. s, H-4 Fur); 6.78 (1H, br. s, H-3
Fur); 7.43–7.49 (3H, m, H-5 Fur, H-3,5 Ph); 7.54–7.63
(3H, m, H-2,4,6 Ph). 13C NMR spectrum (CDCl3), δ, ppm:
14.0 (CH3CH2); 23.1 (2-CH3); 62.3 (ОCH2); 112.4 (C-3
Fur); 113.7 (C-4 Fur); 126.0; 128.0 (C-2,6 Ph); 128.8
(C-3,5 Ph); 129.0; 130.1 (C-4 Ph); 135.2; 142.1; 143.7;
145.3 (C-5 Fur); 150.9; 157.2; 166.7 (С=О).
[4-(Furan-2-yl)-2-methyl-5-nitro-6-phenylpyridin-3-yl]-
(phenyl)methanone (10с). Yield 310 mg (80%), beige
crystals, mp 102–103°С (mp 101–103°С11). IR spectrum,
1
ν, cm–1: 1267, 1351, 1536, 1675, 2925. H NMR spectrum
(CDCl3), δ, ppm (J, Hz): 2.53 (3H, s, CH3); 6.30 (1H, br. d,
J = 5.1, H-4 Fur); 6.62 (1H, d, J = 4.5, H-3 Fur); 7.30 (1H,
br. s, H-5 Fur); 7.42–7.51 (5H, m, H-2–6 Ph); 7.58 (1H, t,
J = 7.5, H-4 PhCO); 7.62–7.69 (2H, m, H-3,5 PhCO); 7.79
(2H, d, J =7.8, H-2,6 PhCO). 13C NMR spectrum (CDCl3),
δ, ppm: 23.3 (2-CH3); 112.3 (C-3 Fur); 114.8 (C-4 Fur);
1130